Bharat Immunological - Quarterly Results
11th Apr 2019

The Total revenue for the quarter ended March 2019 of  Rs. 706.06 millions grew by 225.66% from Rs. 216.81 millions.The Net Loss for the quarter ended March 2019 is Rs. -22.42 millions as compared to Net Loss of Rs. -13.06 millions of corresponding quarter ended March 2018 Operating profit Margin for the quarter ended March 2019 improved to -22.37% as compared to -36.67% of corresponding quarter ended March 2018



(Rs. in Million)


  Quarter ended Year to Date Year ended
  201903 201803 % Var 201903 201803 % Var 201903 201803 % Var
Sales 706.06 216.81 225.66 836.46 347.99 140.37 836.46 347.99 140.37
Other Income 20.91 6.24 235.10 26.38 13.94 89.24 26.38 13.94 89.24
PBIDT -22.37 -36.67 -39.00 -62.87 -68.18 -7.79 -62.87 -68.18 -7.79
Interest 9.29 3.77 146.42 14.92 7.27 105.23 14.92 7.27 105.23
PBDT -31.66 -40.44 -21.71 -77.79 -75.45 3.10 -77.79 -75.45 3.10
Depreciation -0.33 0.54 -161.11 2.76 4.14 -33.33 2.76 4.14 -33.33
PBT -31.33 -40.98 -23.55 -80.55 -79.59 1.21 -80.55 -79.59 1.21
TAX -8.91 -27.92 -68.09 -24.99 -36.97 -32.40 -24.99 -36.97 -32.40
Deferred Tax -8.91 -27.92 -68.09 -24.99 -36.97 -32.40 -24.99 -36.97 -32.40
PAT -22.42 -13.06 71.67 -55.57 -42.57 30.54 -55.57 -42.57 30.54
Equity 431.80 431.80 0.00 431.80 431.80 0.00 431.80 431.80 0.00
PBIDTM(%) -3.17 -16.91 -81.27 -7.52 -19.59 -61.64 -7.52 -19.59 -61.64